Valuation: Avantor, Inc.

Market Cap 10.62B 9.55B 8.91B 8.08B 15.16B 1,011B 15.26B 107B 41.75B 524B 39.87B 39B 1,687B P/E 2026 *
45.5x
P/E 2027 * 33.7x
Enterprise Value 13.65B 12.27B 11.45B 10.38B 19.49B 1,299B 19.61B 137B 53.67B 674B 51.24B 50.13B 2,168B EV / Sales 2026 *
2.07x
EV / Sales 2027 * 1.92x
Free-Float
95.47%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 56 18/08/2025
Director of Finance/CFO 57 21/09/2026
Chief Operating Officer - 10/11/2025
Director TitleAgeSince
Director/Board Member 60 22/04/2020
Chairman 69 01/01/2026
Director/Board Member 62 01/10/2021
Date Insider Type Main position Quantity % Market Cap. Importance
21/09/26 Free

Chief Financial Officer

188,320 0.0276%
18/08/26 Tax

Chief Executive Officer

-29,803 0.0044%
14/08/26 Tax

Head of Human Resources

-181 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.96%+2.28% - - 10.62B
+0.35%+4.29%-22.74%+13.32% 178B
+1.31%+10.20%-2.39%+30.95% 121B
-0.33%+2.26%-23.89%+9.21% 108B
+0.84%+4.51%-44.69%-9.76% 75.7B
+1.84%+5.96%+5.74%+77.89% 64.15B
-1.75%-0.28%+16.15%+64.07% 53.49B
+0.81%+4.85%+0.28%-26.98% 51.45B
+1.67%+4.41%-16.94%+24.13% 41.68B
-1.87%-0.98%+26.07%+9.56% 31.5B
Average +0.39%+3.37%-6.93%+21.37% 73.53B
Weighted average by Cap. +0.46%+4.18%-12.34%+20.28%

Financials

2026 *2027 *
Net sales 6.59B 5.93B 5.53B 5.01B 9.42B 628B 9.47B 66.4B 25.93B 326B 24.76B 24.22B 1,048B 6.74B 6.06B 5.66B 5.13B 9.63B 642B 9.69B 67.91B 26.52B 333B 25.32B 24.77B 1,071B
Net income 225M 203M 189M 171M 322M 21.45B 324M 2.27B 886M 11.13B 846M 828M 35.8B 311M 280M 261M 237M 444M 29.62B 447M 3.13B 1.22B 15.37B 1.17B 1.14B 49.44B
Net Debt 3.03B 2.72B 2.54B 2.3B 4.33B 288B 4.35B 30.51B 11.91B 150B 11.38B 11.13B 481B 2.36B 2.12B 1.98B 1.79B 3.37B 224B 3.39B 23.74B 9.27B 116B 8.85B 8.66B 375B
Projected Income Statement - Annual - Avantor, Inc.
Logo Avantor, Inc.
Avantor, Inc. is a life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. The Company's segments include Bioscience & Medtech Products and VWR Distribution & Services. Through these segments, it provides materials and consumables, equipment and instrumentation and services and specialty procurement to customers in biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and others.
Employees
13,500
Date Price Change
14/10/26 $15.70 +0.96%
13/10/26 $15.55 +0.39%
12/10/26 $15.49 -1.15%
09/10/26 $15.67 +1.82%
08/10/26 $15.39 +0.26%
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Avantor, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
16
Last Close Price
15.70USD
Average target price
15.46USD
Spread / Average Target
-1.50%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Avantor, Inc.
  1. Stock Market
  2. Stocks
  3. AVTR Stock